Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 285
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT02564952 | An Open-label Extension Study to Investigate Possible Drug-drug Interactions Between Clobazam and Cannabidiol | ||
| NCT01080820 | A Safety, Tolerability and Pharmacokinetic Study of a Single Dose of CMX157 in Healthy Volunteers | ||
| NCT00803023 | Safety and Tolerability Study Comparing Sodium Oxybate Given as an Oral Solution to a Single-blinded Combination of Oral Tablets Plus Oral Solution in Subjects With Fibromyalgia | ||
| NCT00710424 | A Study of Sativex® for Pain Relief Due to Diabetic Neuropathy | ||
| NCT05864846 | A Study to Investigate Behavioral and Other Co-Occurring Outcomes With Epidiolex as Add-On Therapy in Participants Aged 1 to 65 Years of Age With Tuberous Sclerosis Complex | ||
| NCT01241344 | Phase 2 Study to Evaluate Brincidofovir for the Prevention of Adenovirus Disease | ||
| NCT02892123 | Trial of ZW25 (Zanidatamab) in Patients With Advanced HER2-expressing Cancers | ||
| NCT04571645 | Dociparstat in Combination With Standard Chemotherapy for the Treatment of Acute Myeloid Leukemia | ||
| NCT05580562 | ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study) | ||
| NCT02224703 | GWPCARE2 A Study to Investigate the Efficacy and Safety of Cannabidiol (GWP42003-P) in Children and Young Adults With Dravet Syndrome | ||
| NCT02525692 | Oral ONC201 in Adult Recurrent Glioblastoma | ||
| NCT06012929 | A Study of ONC201 for Refractory Meningioma | ||
| NCT05875974 | A Study to Investigate the Effect of XYWAV on Sleepiness, Polysomnography, and Functional Outcomes in Participants With Idiopathic Hypersomnia or Narcolepsy | ||
| NCT02224560 | Efficacy and Safety of GWP42003-P for Seizures Associated With Lennox-Gastaut Syndrome in Children and Adults | ||
| NCT01604265 | A Study of Sativex in the Treatment of Central Neuropathic Pain Due to Multiple Sclerosis | ||
| NCT01401140 | Comparing the Protective Effects of Two Cardioplegic Solutions, on Cardiac Metabolism, as Assessed Using Microdialysis | ||
| NCT05392374 | Expanded Access Use of ONC201 in a Patient With Diffuse Intrinsic Pontine Gliomas | ||
| NCT00594256 | Sodium Oxybate in Schizophrenia With Insomnia | ||
| NCT01888120 | Patient Registry of Intrathecal Ziconotide Management(PRIZM) | ||
| NCT03954106 | A Safety and Efficacy Study of Defibrotide in the Prevention of Chimeric Antigen Receptor-T-cell-associated Neurotoxicity | ||
| NCT05642442 | A Study of Suvecaltamide in Adults With Moderate to Severe Residual Tremor in Parkinson's Disease | ||
| NCT04803786 | A Patient-Centric, Prospective, Observational, Non-Interventional Switch Study of XYWAV in Narcolepsy | ||
| NCT02539823 | Acute and Short-term Effects of CBD on Cue-induced Craving in Drug-abstinent Heroin-dependent Humans | ||
| NCT01610700 | An Investigation of Delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) in Multiple Sclerosis Patients | ||
| NCT05169307 | CPX-351 Real-World Effectiveness and Safety Study | ||
| NCT04389840 | Dociparstat for the Treatment of Severe COVID-19 in Adults at High Risk of Respiratory Failure | ||
| NCT01424566 | A Two-Part Study of Sativex® Oromucosal Spray for Relieving Uncontrolled Persistent Pain in Patients With Advanced Cancer | ||
| NCT02091206 | A Dose-ranging Pharmacokinetics and Safety Study of GWP42003-P in Children With Dravet Syndrome (GWPCARE1) | ||
| NCT04541082 | Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms | ||
| NCT06261502 | Effect of CANnabidiol on Anxiety and GABAergic Function in Individuals with Fragile-X Syndrome | ||
| NCT05557045 | A Study of JZP815 Oral Capsules in Adult Participants With Advanced or Metastatic Solid Tumors Harboring Mitogen Activated Protein Kinase (MAPK) Pathway Alterations to Investigate the Safety, Dosing, and Antitumor Activity of JZP815 | ||
| NCT06924827 | A Study to Investigate the Transition of Children From 'Artisanal" Cannabidiol (CBD) to Epidiolex | ||
| NCT04592159 | Study of the Safety and Efficacy of Nabiximols Oromucosal Spray Versus Placebo in Patients With Post-traumatic Stress Disorder | ||
| NCT00598078 | Multiple-dose,Double-blind,Placebo-controlled Study of Sodium Oxybate in Patients With Essential Tremor | ||
| NCT06113237 | Pregnancy Surveillance Program of Patients Exposed to Epidiolex/Epidyolex During Pregnancy | ||
| NCT06143839 | VYxeoS Liposomal Italian Observational Study iN the Real Practice | ||
| NCT01898520 | A Safety, Efficacy and Tolerability Study of Sativex for the Treatment of Spasticity in Children Aged 8 to 18 Years | ||
| NCT04982354 | Induction Therapy for Patients With FLT3 Mutated Acute Myeloid Leukemia | ||
| NCT01606137 | A Study of the Long-term Safety of Sativex Use | ||
| NCT00875693 | A Novel Sequential Treatment of Salvage and Reduced Intensity Conditioning (RIC) Chemotherapy for Allogeneic Stem-Cell Transplantation (SCT) for Primary Refractory and Relapsed Acute Myelogenous Leukemia (AML) | ||
| NCT03526926 | A Post-Marketing Observational Study of VYXEOS™ | ||
| NCT00713817 | A Study to Determine the Maintenance of Effect After Long-term Treatment of Sativex® in Subjects With Neuropathic Pain | ||
| NCT05178316 | A Study of JZP150 in Adults With Posttraumatic Stress Disorder | ||
| NCT03897127 | Study of Standard Intensive Chemotherapy Versus Intensive Chemotherapy With CPX-351 in Adult Patients With Newly Diagnosed AML and Intermediate- or Adverse Genetics | ||
| NCT04269213 | CPX-351 for the Treatment of Secondary Acute Myeloid Leukemia in Patients Younger Than 60 Years Old | ||
| NCT02269579 | Pharmacokinetic and Pharmacodynamic Assessment of Treatment With CPX-351 (Cytarabine: Daunorubicin) Liposome for Injection in Acute Leukemias and MDS Patients With Moderate Hepatic Impairment | ||
| NCT02647190 | Intravenous Erwinia Chrysanthemi Asparaginase in Patients With Newly Diagnosed Philadelphia Chromosome Negative Acute Lymphoblastic Leukemia Aged 60 Years or Older | ||
| NCT04291937 | A Multicenter Expanded Access Treatment Protocol of Lurbinectedin in Previously Treated SCLC in the USA | ||
| NCT07102381 | A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer | ||
| NCT05918640 | Lurbinectedin in FET-Fused Tumors |
